“Dueling Numbers”: FDA Panel Trying to Determine Safety of Paclitaxel-Coated Stents and Balloons - PharmaLive

“Dueling Numbers”: FDA Panel Trying to Determine Safety of Paclitaxel-Coated Stents and Balloons  PharmaLive

Published: June 20, 2019. By Mark Terry. FDA3. The U.S. Food and Drug Administration (FDA)'s Circulatory System Devices Panel is in the middle of two days ...



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more